# Advanced Development of Vaccines for Infectious Diseases

> **NIH NIH N01** · GREFFEX, INC. · 2020 · $2,955,109

## Abstract

The primary objective of this project is to support the advanced development of candidate products for use in post-event settings following the intentional release of or in response to naturally occurring outbreaks of infectious diseases caused by NIAID Category A, B, and C Priority Pathogens. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in nonhuman primates, IND enabling GLP repeated dose toxicology, submission of an IND and eventual clinical evaluation.

## Key facts

- **NIH application ID:** 10074410
- **Project number:** 75N93019C00061-P00001-9999-1
- **Recipient organization:** GREFFEX, INC.
- **Principal Investigator:** UWE STAERZ
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $2,955,109
- **Award type:** —
- **Project period:** 2019-09-09 → 2021-01-08

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10074410

## Citation

> US National Institutes of Health, RePORTER application 10074410, Advanced Development of Vaccines for Infectious Diseases (75N93019C00061-P00001-9999-1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10074410. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*